MPM Asset Management LLC
- SEC CIK
- 0001263048
- Latest filing
- Nov 14, 2025
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 6
- 0 vs. Q1 2024
- Portfolio value
- $182.1M
- −$63.1M (−25.7%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TRDAEntrada Therapeutics, Inc. | COM | 4,425,784 | $63.1M | 34.6% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 1,561,496 | $55.1M | 30.3% | −1,889,807−54.8% | Reduced | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,738,785 | $40.6M | 22.3% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 4,284,172 | $10.5M | 5.7% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 2,242,636 | $7.40M | 4.1% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 5,555,461 | $5.42M | 3.0% | 00.0% | Unchanged | History |